Kenvue Inc. Common Stock vs Lumentum — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while Lumentum trades at $1,103.36 (market cap $94.99B). The key difference: Lumentum is far larger — about 2.8× Kenvue Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Lumentum pays none. Which is the better fit depends on your goals.
| KVUE | LITE | |
|---|---|---|
Market Cap | $34.06B | $94.99B |
Volume | 23,267,228 | 4,855,776 |
Sector | Consumer Staples | Technology |
52-Week High | $19.83 | $1.13K |
52-Week Low | $14.11 | $149.61 |
Enterprise Value | $41.56B | $93.92B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 4 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →